Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 8, Issue Suppl 3
399 Cosibelimab, an anti-PD-L1 antibody: preliminary safety and efficacy results from a global, multicohort phase 1 clinical trial
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and young investigator award abstracts
Clinical trials in progress
399 Cosibelimab, an anti-PD-L1 antibody: preliminary safety and efficacy results from a global, multicohort phase 1 clinical trial
Online download statistics by month:
Online download statistics by month: November 2020 to September 2024
Abstract
Full
Pdf
Nov 2020
145
0
13
Dec 2020
30
0
5
Jan 2021
37
0
2
Feb 2021
53
0
6
Mar 2021
145
0
25
Apr 2021
72
0
14
May 2021
28
0
13
Jun 2021
0
0
7
Jul 2021
0
0
10
Aug 2021
0
0
11
Sep 2021
0
0
18
Oct 2021
94
0
28
Nov 2021
358
0
28
Dec 2021
283
0
14
Jan 2022
118
0
10
Feb 2022
100
0
10
Mar 2022
124
0
4
Apr 2022
92
0
4
May 2022
104
0
6
Jun 2022
110
0
13
Jul 2022
144
0
3
Aug 2022
108
0
4
Sep 2022
92
0
6
Oct 2022
85
0
4
Nov 2022
68
0
6
Dec 2022
54
0
3
Jan 2023
62
0
4
Feb 2023
58
0
8
Mar 2023
38
0
3
Apr 2023
30
0
4
May 2023
56
0
2
Jun 2023
34
0
2
Jul 2023
42
0
4
Aug 2023
46
0
2
Sep 2023
26
0
3
Oct 2023
22
0
3
Nov 2023
44
0
3
Dec 2023
76
0
5
Jan 2024
16
0
0
Feb 2024
32
0
0
Mar 2024
52
0
6
Apr 2024
32
0
5
May 2024
38
0
3
Jun 2024
36
0
0
Jul 2024
22
0
6
Aug 2024
14
0
2
Sep 2024
24
0
1
Total
3244
0
333
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?